|
|
Home | Contact Us | Press Room | Site Overview | Help | Login | Register |
![]() |
![]() |
| About NCSL | State & Federal Issues | Legislatures | Legislative Staff | Meetings | Bookstore | Legislators & Staff Only |
| NCSL Home > State & Federal Issues: Issue Areas >Health > | Add to MyNCSL |
Mapping Public Policy for Genetic TechnologiesPreface and AcknowledgmentsNCSL gratefully acknowledges the many individuals who helped make this publication possible. Dr. Ken Cullver (ONCOR); Senator Jennie Forehand, Maryland; Senator James J. Lack, New York; W. Martin Strauss and Frank Santos (Monsanto); Lewis Maltby (American Civil Liberties Union); Mark A. Rothstein, (University of Houston and Houston Law Center); Barry Gershon and Spencer Guthrie (SmithKline Beecham Pharmaceuticals) who deserve special recognition for their expertise and the substantial amount of time they contributed.Vicky Rodriguez, NCSL staff assistant to the project, devoted many hours to producing this publication by overseeing the entire document process, working with the editors and formatting the document.
To Next Section: Executive Summary
|
© 2008 National Conference of State Legislatures, All Rights Reserved
Denver Office: Tel: 303-364-7700 | Fax: 303-364-7800 | 7700 East First Place | Denver, CO 80230 | Map
Washington Office: Tel: 202-624-5400 | Fax: 202-737-1069 | 444 North Capitol Street, N.W., Suite 515 | Washington, D.C. 20001